Localization of platelet-activating factor receptor messenger RNA in the rat eye

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 12, 1997, Pages 2672-2678

  Mori, Mikiro ^a   Aihara, Makoto ^a   Shimizu, Takao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Eye; In situ hybridization; Platelet activating factor; Receptor

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; CILIARY BODY; CORNEA EPITHELIUM; EYE; IN SITU HYBRIDIZATION; IRIS; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE;

ANIMALS; CHOROID; CILIARY BODY; DNA PRIMERS; EPITHELIUM, CORNEAL; EYE; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; IRIS; MALE; NEUROGLIA; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RETINAL GANGLION CELLS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0030730878     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Ann Rev Biochem. 1986; 55:483-509.
2. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987;39:97-145.
3. Izumi T, Shimizu T. Platelet-activating factor receptor: Gene expression and signal transduction. Biochim Biophys Acta. 1995;1259:317-333.
4. Bussolino F, Gremo F, Tetta C, Pescarmona GP, Camussi G. Production of platelet-activating factor by chick retina. J Biol Chem. 1986;261:16502-16508.
5. Dharma S, Bazan HE, Peyman GA, Atef MS. Production of platelet-activating factor in photocoagulated retinas. Curr Eye Res. 1991;10:1031-1035.
6. Bazan HE, Reddy ST, Woodland JM, Bazan NG. The accumulation of platelet-activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Biochem Biophys Res Commun. 1987;149:915-920.
7. Bazan HE, Reddy ST, Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res. 1991;52:481-491.
8. Ito Y, Sugatani J, Miki H, Uyama M, Saito K. Corneal PAF acetylhydrolase increases in anterior segment ischemia in rabbits. Exp Eye Res. 1993;57:107-115.
9. Rosenbaum JT, Boney RS, Samples JR, Valone FH. Synthesis of platelet-activating factor by ocular tissue from inflamed eyes. Arch Ophthalmol. 1991;109:410-413.
10. Tjebbes GW, van Delft JI, van Haeringen Nj. Production of lipid mediators in experimental keratitis of rabbit eye. J Lipid Mediat. 1993,8:87-93.
11. Yousufzai SY, Abdel LA. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. Biochem J. 1985;228:697-706.
12. Hurst JS, Bazan HE. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea. Curr Eye Res. 1995;14:769-775.
13. Tao Y, Bazan HE, Bazan NG. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. Invest Ophthalmol Vis Sci. 1996;37:2037-2046.
14. Bazan HE, Tao Y, Bazan NG. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc Natl Acad Sci USA. 1993;90:8678-8682.
15. Tao Y, Bazan HE, Bazan NG. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Invest Ophthalmol Vis Sci. 1995;36:345-354.
16. Cohen RA, Gebhardt BM, Bazan NG. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization. Curr Eye Res. 1994;13:139-144.
17. van Haeringen NJ, Verbey NL, van Delft JI. Antagonists and inhibitors of lipid mediators in experimental inflammation of the cornea. J Ocul Pharmacol. 1993; 9:365-372.
18. Bazan HE, Braquet P, Reddy ST, Bazan NG. Inhibition of the alkali burn-induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet activating factor antagonist. J Ocul Pharmacol. 1987; 3:357-365.
19. Sheng Y, Birkle DL. Release of platelet-activating factor (PAF) and eicosanoids in UVG-irradiated corneal stromal cells. Curr Eye Res. 1995;14:341-347.
20. Jager GV, van Delft JI, van Haeringen Nj, Verbeij NL, Braquet P. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits. Prostaglandins. 1993;45:97-105.
21. Verbey NL, van Delft JI, van Haeringen Nj, Braquet P. Platelet-activating factor and laser trauma of the iris. Invest Ophthalmol Vis Sci. 1989;30:1101-1103.
22. Rubin RM, Rosenbaum JT. A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. Biochem Biophys Res Commun. 1988;154:429-436.
23. Lin N, Bazan HE, Braquet P, Bazan NG. Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis. Curr Eye Res. 1991;10:19-24.
24. Fleisher LN, Ferrell JB, Smith MG, McGahan MC. Lipid mediators of tumor necrosis factor-alpha-induced uveitis. Invest Ophthalmol Vis Sci. 1991;32:2393-2399.
25. Reme C, Wei Q, Munz K, Jung H, Doly M, Droy LM. Light and lithium effects in the rat retina: Modification by the PAF antagonist BN 52021. Graefes Arch Clin Exp Ophthalmol 1992;230:580-588.
26. Doly M, Cluzel J, Millerin M, Bonhomme B, Braquet P. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. Ophthalmic Res. 1993;25:314-318.
27. Menerath JM, Cluzel J, Droy-Lefaix MT, Doly M. Experimental electroretinographic exploration of retinal ischemia: Preventive use of free radical scavengers and anti-PAF agents. J Ocul Pharmacol Ther. 1997; 13:81-88.
28. Domingo MT, Chabrier PE, van Delft JL, Verbeij NL, van Haeringen NJ, Braquet P. Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit. Biochem Biophys Res Commun. 1989;160:250-256.
29. Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G. Presence of specific platelet-activating factor binding sites in the rat retina. Eur J Pharmacol. 1989;163:97-101.
30. Honda Z, Nakamura M, Miki I, et al. Cloning by functional expression of platelet-activating factor receptor from guinea pig lung. Nature. 1991;349:342-346.
31. Bito H, Honda Z, Nakamura M, Shimizu T. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem. 1994; 221:211-218.
32. Mori M, Aihara M, Kume K, Hamanoue M, Kohsaka S, Shimizu T. Predominant expression of platelet-activating factor receptor in the rat brain microglia. J Neurosci. 1996;16:3590-3600.
33. Marcheselli VL, Rossowska MJ, Domingo M, Braquet P, Bazan NG. Distinct platelet-activating factor binding sites in synaptic endings and intracellular membranes of rat cerebral cortex. J Biol Chem. 1990; 265:9140-9145.
34. Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA. 1994;91:5252-5256.
35. Ishii S, Nagase T, Tashiro F, et al. Bronchial hyperreactivity, increased endotoxin lethality, and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 1997; 16:133-142.
36. Honda Z, Takano T, Gotoh Y, Nishida E, Ito K, Shimizu T. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem. 1994;269:2307-2315.
37. Mori M, Bito H, Sakanaka C, et al. Activation of mitogen-activated protein (MAP) kinase and arachidonate release via two G protein-coupled receptors expressed in the rat hippocampus. Ann NY Acad Sci. 1994; 744:107-125.
38. Murphy S, Welk G. Hydrolysis of polyphosphoinositides in astrocytes by platelet-activating factor. Eur J Pharmacol. 1990;188:399-401.
39. Yue TL, Stadel JM, Sarau HM, et al. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. Mol Pharmacol. 1992; 41:281-289.
40. Kornecki E, Ehrlich YH. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science. 1988;240:1792-1794.
41. Kornecki E, Ehrlich YH. Calcium ion mobilization in neuronal cells induced by PAF. Lipids. 1991;26:1243-1246.
42. Ferby I, Waga I, Hosino M, Kume K, Shimizu T. Wortmannin inhibits mitogen-activated protein kinase, by a mechanism independent of p85/p110 phosphatidylinositol 3 kinase inhibition. J Biol Chem. 1996; 271:11684-11688.
43. Muller A, Meynier F, Bonne C. PAF-induced conjunctivitis in the rabbit is mediated by peptido-leukotrienes. J Ocul Pharmacol. 1990;6:227-237.
44. Stock EL, Roth SI, Kim ED, Walsh MK, Thamman R. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva. Invest Ophthalmol Vis Sci. 1990;31:987-992.
45. Gelbard HA, Nottet HS, Swindells S, et al. Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol. 1994;68:4628-4635.
46. Nishida K, Markey SP, Kustova Y, et al. Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated. J Neurochem. 1996;66:433-435.
47. Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol. 1991;113:10-17.
48. Lombardi G, Moroni F, Moroni F. Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur J Pharmacol. 1994;271:489-495.
49. Barron KD. The microglial cell. A historical review. J Neurol Sci. 1995;134:57-68.
50. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985; 223:69-76.
51. Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye. 1990;613-621.
52. van der Schaft T, Mooy CM, de Bruijn W, de Jong P. Early stages of age-related macular degeneration: An immunofluorescence and electron microscopy study. Br J Ophthalmol. 1993;77:657-661.
53. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol. 1996;156:1-4.
54. Gottschall PE, Yu X, Bing B. Increased production of gelatinase B (matrix metalloproteinase 9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res. 1995;42:335-342.